Abstract:Background: The unique situation of the liver with arterial and venous blood supply and the dependency of the tumor on the arterial blood flow make this organ an ideal target for intrahepatic catheter-based therapies. Main forms of treatment are classical bland embolization (TAE) cutting the blood flow to the tumors, chemoembolization (TACE) inducing high chemotherapy concentration in tumors, and radioembolization (TARE) without embolizing effect but very high local radiation. These different forms of therapies are used in different centers with different protocols. This overview summarizes the different forms of treatment, their indications and protocols, possible side effects, and available data in patients with non-colorectal liver tumors. Methods: A research in PubMed was performed. Mainly clinical controlled trials were reviewed. The search terms were 'embolization liver', 'TAE', 'chemoembolization liver', 'TACE', 'radioembolization liver', and 'TARE' as well as 'chemosaturation' and 'TACP' in the indications 'breast cancer', 'neuroendocrine', and 'melanoma'. All reported studies were analyzed for impact and reported according to their clinical relevance. Results: The main search criteria revealed the following results: 'embolization liver + breast cancer', 122 results, subgroup clinical trials 16; 'chemoembolization liver + breast cancer', 62 results, subgroup clinical trials 11; 'radioembolization liver + breast cancer', 37 results, subgroup clinical trials 3; 'embolization liver + neuroendocrine', 283 results, subgroup clinical trials 20; 'chemoembolization liver + neuroendocrine', 202 results, subgroup clinical trials 9; 'radioembolization liver + neuroendocrine', 64 results, subgroup clinical trials 9; 'embolization liver + melanoma', 79 results, subgroup clinical trials 15; 'chemoembolization liver + melanoma', 60 results, subgroup clinical trials 14; 'radioembolization liver + melanoma', 18 results, subgroup clinical trials 3. The term 'chemosaturation liver' was tested without indication since only few publications exist and provided us with five results and only one clinical trial. Conclusion: Despite many years of clinical use and documented efficacy on intra-arterial treatments of the liver, there are still only a few prospective multicenter trials with many different protocols. To guarantee the future use of these efficacious therapies, especially in the light of many systemic or surgical therapies in the treatment of non-colorectal liver metastases, further large randomized trials and transparent guidelines need to be established.

Role of inferior phrenic artery in the interventional treatment of lung metastases tumor: A report of 11 cases.

Inferior Phrenic Artery As the Feeding Artery of Liver Cancer: Its Significance in TACE

[Clinical Effect of Terminal Branches Portal Vein Embolization Combined with Transcatheter Arterial Chemoembolization on Liver Neoplasms].

Safety of transcatheter arterial chemoembolization for hepatocellular carcinoma via the inferior phrenic artery

Transcatheter Arterial Chemoembolization Experience for Advanced Hepatocellular Carcinoma with Right Atrial Tumor Thrombus

[Extrahepatic Collateral Arteries Are Involved in the Blood Supply to Hepatocellular Carcinoma: Angiographic Demonstration and Transcatheter Arterial Chemoembolization].

The significance of anomalous arterial blood supply of liver cancer in interventional therapy

Arterial Therapies of Non-Colorectal Liver Metastases

Retrospective Analysis of Interventional Treatment of Hepatic Metastasis from Gastroenteropancreatic Neuroendocrine Tumors.

Interventional Radiology Treatment of Liver Metastasis Caused by Breast Cancer

Features of blood supply and results of transarterial infusion and embomization in spinal metastases

[Surgical Treatment of Tumor Invading Important Vessel].

Imaging characteristics and intervention therapy for hepatic artery-portal vein shunts in patients with primary liver carcinoma

Transarterial embolization for the management of emergent hemoptysis in patients with primary and metastatic lung tumors

Computed Tomography Arteriography for Detecting the Origin of the Inferior Pyloric Artery in Patients with Gastric Cancer

Increased Metastatic Potential of Residual Carcinoma after Transarterial Embolization in Rat with McA-RH7777 Hepatoma.

Application of Bronchial Arterial Chemoembolization for Treating Advanced Lung Cancer

Hepatic transcatheter arterial infusion and chemoembolization in the treatment of liver metastases of neuroendocrine tumors

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

Interstitial Injection of 32P-Chromic Phosphate During Lung Cancer Resection to Treat Occult Lymphatic Metastasis

Rare infiltrative primary hepatic angiosarcoma: A case report and review of literature